Biofrontera AG American Depositary Shares (BFRA)

BFRA was delisted on the 4th of March, 2022.

• Market cap: $75.7M
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Biofrontera AG is active in the field of healthcare in the United Kingdom. It manufactures pharmaceutical products, especially medical cosmetics and dermatological drugs for the care and treatment of skin diseases. Its suite of products includes the prescription drugs Ameluz and BF-RhodoLED, for the treatment of actinic keratosis and Belixos, for the regenerative care of reddened and inflamed skin.

Employees: 167